Single-Cell Proteomic Pathway Omics
Identifying adaptive signaling pathways for designing improved targeted therapies
Therapeutics
Thermo Fisher Scientific Launches First T-Cell Medium Designed Specifically for Allogeneic Cell Therapy Workflows
Novel media supports automated T-cell expansion to deliver scalable, cost-effective cell therapy treatments
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks
Future-Proof Your HCP Strategy
Robust and accurate HCP measurement is crucial throughout biologics development
Challenging Host Cell Protein Assays
FAQs about improving risk mitigation by challenging host cell protein assays
Host Cell Protein Control Solutions
Find solutions, expertise, and support to advance and accelerate therapeutics
Don't Leave Antibody Performance to Chance
Antibody validation and quality control strategies ensure high specificity and reproducibility for optimal performance
Recent Developments in Proteolysis Targeting Chimeras
In this Q&A, Craig Crews, PhD, discusses the discovery and development of proteolysis targeting chimeras, a new modality that is being explored for both drug discovery and therapeutic application
Quantify and Characterize Host Cell Protein With Confidence
Prevent costly HCP underestimation with a robust CHO Supernatant ELISA Kit
Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing
The CTS Rotea system is the first Gibco instrument for cell therapy processing applications